---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-027746"
form_type: "8-K"
ticker: "PURE"
cik: "0001006028"
company_name: "PURE BIOSCIENCE, INC."
filed_at: "2025-12-15T23:59:59+00:00"
generated_at: "2026-05-16T13:09:31.377756+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# PURE Bioscience reports fiscal Q1 2026 revenue up 27% to $707K, net loss narrows to $464K

## Summary
- Net product sales $707K for Q1 ended Oct 31, 2025, up 27% from $555K YoY.
- Net loss $464K vs $689K year ago; net loss per share ($0.00) vs ($0.01).
- Adjusted net loss (excl. share-based comp) was $430K vs $632K.
- PURE Control now treating leafy greens for commercial sale; traction in transportation with SDC-powered sanitation.
- Working with distribution partners in beverage and dairy to roll out membrane treatment solutions.

## SEC filing metadata
- accession: 0001493152-25-027746
- form_type: 8-K
- ticker: PURE
- cik: 0001006028
- company_name: PURE BIOSCIENCE, INC.
- filed_at: 2025-12-15T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1006028/000149315225027746/0001493152-25-027746-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1006028/000149315225027746/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-027746
- JSON: https://secwatch.observer/filing/0001493152-25-027746.json
- Plain text: https://secwatch.observer/filing/0001493152-25-027746.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.